David Gonyer | executive |
Christopher Quesenberry | executive |
Matthew D'Onofrio | executive |
Yale Jen | analyst |
Good afternoon, and welcome to the Evoke Pharma Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's call is being recorded.
I will now turn the call over to Daniel Kontoh-Boateng. Please go ahead, sir.
Good afternoon, and thank you for participating in Evoke Pharma's conference call and webcast today.